‘Holly's Law’ needed to protect women from RU-486, says USCCB office
Imprimir Incrementar tamaño de fuente Disminuir tamaño de fuente

.- A public workshop in response to women’s deaths linked to abortion drug RU-486 was a “constructive step,” but it does not lessen the need for a law to suspend the drug, says an official with the U.S. Conference of Catholic Bishops (USCCB).

Several deaths have been linked to RU-486, also known as “Mifeprex.” Five American women died from infections after undergoing RU-486 abortions, and another died from an undiagnosed ruptured ectopic pregnancy. Over 800 others have suffered serious or life-threatening adverse health effects. Women in Canada, Sweden and the United Kingdom have also died after taking RU-486.

The May 11 workshop, held in Atlanta, was convened by the U.S. Food and Drug Administration (FDA) and co-sponsored by the Centers for Disease Control and the National Institutes of Health.

Deirdre McQuade, director of planning and information at the USCCB Secretariat for Pro-Life Activities, attended the event.

“Women seeking elective chemical abortions remain at risk with RU-486 on the market,” she said. McQuade said the USCCB continues to call for the passage of Holly’s Law.

The legislation “would temporarily suspend FDA approval of RU-486 while its approval process is reviewed,” McQuade explained.

“Holly’s Law” (H.R. 1079) is named in memory of Holly Patterson, a young California woman who died from septic shock after undergoing an RU-486 abortion.

Imprimir Incrementar tamaño de fuente Disminuir tamaño de fuente
ADD A COMMENT (Your e-mail will NOT be published):
NAME:
CITY/STATE/COUNTRY:
EMAIL:
COMMENT:
 
PLEASE ENTER THE SECURITY CODE DISPLAYED ABOVE:
Chars:
* Thanks for your comments. The number of messages that can be online is limited. Length should not exceed 1500 characters. CNA reserves the right to edit messages for content and tone. Comments and opinions expressed by users do not necessarily reflect the opinions or beliefs of CNA. CNA will not publish comments with abusive language, insults or links to other pages.
ADVERTISING
Place your ad here
Resources:
Columns:
News:
Documents:
Tools:
ACI Group:
ACI Prensa